Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2019 Symposium /
Data sharing and system interoperability: The Osiris French Program

23rd - 24th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.07.19
Views: 299
Rating:

Dr Pierre Saintigny - Centre Léon Bérard, Lyon, France

Dr Pierre Saintigny speaks to ecancer at the WIN 2019 Symposium in Paris about a new initiative that uses the exchange of clinical and genetic data from patients that have been included in precision medicine or molecular triage clinical trials.

He explains the idea and structure behind this program, which aims to learn more about some of the more obscure genomic alterations and to determine their association with certain drugs.

Dr Saintigny also describes how data quality is ensured, which incorporates both clinical and genomic items into models that take the long-term evolution of the patient into account.

For the future, this initiative will include more retrospective patients and to utilise this data in a prospective manner.

Dr Saintigny also discusses the possibility of expanding the initiative on a global scale.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation